• SENSEX 76,420.61
    -196.83 (--0.26%)
  • BANKNIFTY 51,348.05
    520.55 (+1.02%)
  • Tejas Networks
    902.70 1,495.10(%)
  • Mazagon Dock
    2,716.00 2,929.98(%)
  • Kalyan Jewellers
    497.15 337.00(%)
  • Adani Power
    538.00 896.75(%)
  • Hind.Aeronautics
    4,305.95 5,675.00(%)
  • TCS
    3,416.60 3,457.35(%)
  • Reliance Industr
    1,234.55 1,156.00(%)
  • Bharat Electron
    287.80 340.35(%)
  • Vodafone Idea
    8.06 6.60(%)
  • Tata Motors
    655.20 606.20(%)
  • Zydus Lifesci.
    949.85 1,323.90(%)
  • IndusInd Bank
    714.65 1,576.00(%)
  • Zomato Ltd
    214.00 304.50(%)
  • Reliance Power
    44.44 54.25(%)
  • ICICI Pru. BSE
    1,000.00 998.75(%)
  • Aurobindo Pharma
    1,267.95 1,592.55(%)
  • Piramal Enterp.
    977.85 736.60(%)
  • Persistent Sys
    4,828.60 3,232.60(%)
  • HDFC Bank
    1,799.50 1,880.00(%)
  • Wockhardt
    1,424.20 489.20(%)
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison
Overview
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison

Zydus Lifesciences Ltd Pharmaceuticals - Indian - Bulk Drugs & Formln

  • Cadila
  • BSE Code : 20883.0
  • ISIN : INE010B01027
891.15 14 (1.56%)
  • As on 03 Apr 2025 (EOD)

  • Today’s Low

    862.80

  • Today’s High

    895.25

  • Open

    870.25

  • Perv Close

    877.50

  • 52W Low

    855.10

  • 52W High

    1,324.30

Key Indicators

  • P/E(TTM)

    20.51

  • Mar.Cap (₹Cr.)

    89,670.54

  • Div & Yield %

    0.34

  • Book Value(₹)

    177.87

  • Debt-Equity Ratio

    1.56

  • AGM Date

    02-Apr-2025

  • EPS

    43.46

  • P/E Ratio

    20.51

Financials Ratios

  • Debt-Equity Ratio

    0.05

  • Mar.Cap (₹Cr.)

    89,670.54

  • RONW (%)

    20.64

  • ROCE (%)

    23.94

Score Board

  • Equity (₹ in Cr.)

    100.62

  • BV (₹)

    177.90

  • Sales( ₹ in Cr.)

    10,818.70

  • NP (in Cr.)

    3,437.60

  • NP Var(%)

    112.0

  • Div%

    300.0

  • CPS (₹)

    39.20

  • EPS (₹)

    34.20

  • Traded Value (₹ in Lakhs)

    89,680.60

  • 52 Week High

    1,324.30

  • 52 Week Low

    855.10

  • Price BSE

    891.0

  • Price NSE

    891.00

  • Market Capital( in Cr.)

    89,680.60

  • P/C Ratio

    22.70

  • P/E Ratio

    26.10

  • Price Vs.BV

    34.20

View More
Invest Now!

Navigate The Market With Confidence

Your all-in-one destination for expert investment guidance and streamlined portfolio management solutions

Financials

All Values are in (₹Cr)
Particulars(INCOME) Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Mar 2019
Sales Turnover 10,818.70 8,731.60 7,836.90 7,780.00 6,347.40 6,037.40
Excise Duty 10,317.60 8,421.20 7,590.00 7,436.70 5,967.70 5,746.60
Net Sales 10,818.70 8,731.60 7,836.90 7,780.00 6,347.40 6,037.40
Other Income 1,084.80 548.40 178.70 89.30 849.40 559.30
Stock Adjustments 0.00 0.00 0.00 0.00 0.00 0.00
Total Income 11,903.50 9,280.00 8,015.60 7,869.30 7,196.80 6,596.70
EXPENDITURE :
Raw Materials 10,317.60 8,421.20 7,590.00 7,436.70 5,967.70 5,746.60
Power & Fuel Cost 10,317.60 8,421.20 7,590.00 7,436.70 5,967.70 5,746.60
Employee Cost 1,507.50 1,321.90 1,204.90 1,147.30 1,077.40 961.20
Other Manufacturing Expenses 438.20 133.10 259.00 406.90 434.20 280.00
Selling & Administrative Expenses 1,016.00 1,039.80 958.40 1,009.10 925.30 755.00
Miscellaneous Expenses 438.20 133.10 259.00 406.90 434.20 280.00
Less : Pre-operative Expenses Capitalised :
Total Expenditure 7,655.10 7,044.00 6,532.40 5,993.30 5,587.10 4,855.40
Operating Profit 645.40 611.10 626.30 556.60 535.70 547.20
Interest 390.70 278.20 134.90 70.90 233.90 89.60
Gross Profit 4,239.80 2,032.20 1,163.90 1,688.50 1,557.70 1,741.30
Depreciation 504.40 488.60 478.70 451.10 428.90 358.20
Profit Before Tax 4,239.80 2,032.20 1,163.90 1,688.50 1,557.70 1,741.30
Tax 934.30 464.10 260.20 303.20 164.60 334.90
Fringe Benefit tax 0.00 0.00 0.00 0.00 0.00 0.00
Deferred Tax -136.00 41.20 45.80 -91.00 40.00 -33.90
Reported Net Profit 3,441.50 1,529.20 857.90 1,476.20 1,353.60 1,439.80
Extraordinary Items 4,239.80 2,032.20 1,163.90 1,688.50 1,557.70 1,741.30
Adjusted Net Profit 3,441.50 1,529.20 857.90 1,476.20 1,353.60 1,439.80
Adjustment below Net Profit 0.00 0.00 0.00 0.00 0.00 0.00
P & L Balance brought forward 0.00 0.00 0.00 0.00 68.20 55.20
Statutory Appropriations 301.87 607.32 255.94 358.31 358.31 358.31
P & L Balance carried down 3,441.50 1,529.20 857.90 1,476.20 1,353.60 1,439.80
Dividend - - - - - -
Preference Dividend - - - - - -
Equity Dividend (%) 300.00 600.00 250.00 350.00 350.00 350.00
Dividend Per Share(Rs) 3.00 6.00 2.50 3.50 3.50 3.50
Earnings Per Share-Unit Curr 34.01 15.06 8.38 14.42 13.80 14.51
Book Value 301.87 607.32 255.94 358.31 358.31 358.31
Book Value(Adj)-Unit Curr 301.87 607.32 255.94 358.31 358.31 358.31

Shareholding Pattern

  • Promoter Group

    74.98%

  • Public Share Holding

    25.02%

Category of Shareholder No of Shares % Holdings Demat Shares Shareholders
A]. Promoter & Group
Foreign (Promoter & Group) - Bodies Corporate 0 0.00 0 0
Foreign (Promoter & Group)-Individuals (Non-Resident / Foreign) 0 0.00 0 0
Foreign Promoter(Institutional) 0 0.00 0 0
Promoter Others 0 0.00 0 0
Sub Total 0 0.00 0 0
[2] INDIAN
Bodies Corporate-Indian (Promoter & Group) 17,730 0.00 17,730 1
Government(Central / State)-Indian (Promoter & Group) 0 0.00 0 0
Directors & their Relatives-Indian (Promoter & Group) 0 0.00 0 0
Financial Institutions / Banks-Indian (Promoter & Group) 0 0.00 0 0
Individuals / Hindu Undivided Family-Indian (Promoter & Group) 118,201 0.01 118,201 5
Partnership Firms-Indian (Promoter & Group) 0 0.00 0 0
Persons Acting in Concert 0 0.00 0 0
Trusts 754,328,118 74.97 754,328,118 2
Others 0 0.00 0 0
Sub Total 754,464,049 74.98 754,464,049 8
Total ShareHolding for Promoter & Group
B]. Publice Share Holding
1] Institution
Government(Central / State) 10,071 0.00 10,071 3
Clearing Members 0 0.00 0 0
Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
Financial Institutions / Banks 20,594 0.00 18,284 4
Foreign Bank 0 0.00 0 0
Foreign Bodies Corporate/OCBs/FBC 0 0.00 0 0
Foreign Collaborators 0 0.00 0 0
Foreign Institutional Investors 75,774,998 7.53 75,774,998 624
Foreign Venture Capital Investors 0 0.00 0 0
Foreign Institution Other 0 0.00 0 0
Insurance Companies 41,051,689 4.08 41,051,689 16
Mutual Funds / UTI 63,560,910 6.32 63,560,910 31
Individuals (Non-Resident / Foreign) 0 0.00 0 0
NSDL Intransit 0 0.00 0 0
Others 2,562,129 0.25 2,562,129 18
Trusts 0 0.00 0 0
Venture Capital Funds 0 0.00 0 0
Sub total 182,980,391 18.18 182,978,081 696
2] Non Institution
Bodies Corporate 6,496,627 0.65 6,496,627 1,031
Clearing Members 2,533 0.00 2,533 13
Directors of their Relatives 372,464 0.04 372,464 5
Employees 0 0.00 0 0
Escrow Account 0 0.00 0 0
Foreign Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
NRIs/Foreign Individuals/Foreign Nationals 2,877,938 0.29 2,871,113 7,330
Foreign Non Institution Other 0 0.00 0 0
Hindu Undivided Families 1,493,622 0.15 1,492,872 4,134
Indian Public 0 0.00 0 0
Individuals holding nominal share capital in excess of Rs. 1 lakh 7,869,060 0.78 7,869,060 8
Individuals holding nominal share capital up to Rs. 1 lakh 47,196,134 4.69 45,814,834 352,002
Market Maker 0 0.00 0 0
NSDL Transit 0 0.00 0 0
Shares in transit 0 0.00 0 0
Societies 0 0.00 0 0
Trust & Foundation 234,256 0.02 234,256 25
Others 1,796,375 0.18 1,796,375 4
Sub Total 68,789,550 6.84 67,400,675 364,652
Total Public Shareholding
C]. Shares held by Custodians and against which Depository Receipts have been issued
ADR 0 0.00 0 0
GDR 0 0.00 0 0
Other Custodians 0 0.00 0 0
Total Shares held by Custodians and against which Depository Receipts have been issued 0 0.00 0 0
Grand Total ( A + B + C ) 1,006,233,990 100.00 1,004,842,805 365,356

Company Background

Zydus Lifesciences LtdPharmaceuticals - Indian - Bulk Drugs & Formln

  • Zydus Lifesciences Ltd
  • BSE Code : 20883.0
  • ISIN : INE010B01027

  • Incorporation Year

    1995

  • Registered Office

    Zydus Corporate Park S No 536
    Khoraj Sarkhej-Gandhinagar H/W, Ahmedabad,
    Gujarat-382481

  • Telephone

    91-079-26868100

  • FAX

    91-079-26868337/26862365/26862366

  • Chairman

    Pankaj R Patel

  • Managing Director

    Sharvil P Patel

  • Company Secretary

    Dhaval N Soni

  • Auditor

    Deloitte Haskins & Sells LLP

  • Face Value

    1

  • Listing

    NSE

  • Registrar

    Link Intime India Pvt Ltd
    5th Floor 506 to 508,
    ABC-I Off C G Road ,Navrangpura
    Mumbai - Ahmedabad-380009

Zydus Lifesciences Ltd Peer Comparison

Profit & Loss
Financial Ratios
Balance Sheet
Select Company Name LTP (₹) Revenue Sales P/E Ratio ROCE %
Zydus Lifesci. 891.25 11,903.50 10,818.70 20.54 22.73
Abbott India 29,572.60 6,097.18 5,848.91 47.09 44.71
Astrazeneca Phar 8,100.10 1,330.33 1,295.53 208.82 33.26
P & G Health Ltd 5,259.35 1,166.89 1,151.26 36.90 39.76
Glaxosmi. Pharma 2,776.60 3,530.73 3,407.25 55.21 44.44
Cipla 1,452.70 17,645.00 16,574.34 24.90 20.10
Amrutanjan Healt 645.10 437.58 421.23 37.81 20.84
Fermenta Biotec. 292.05 315.24 307.09 27.68 4.10
Guj. Themis Bio. 272.20 174.19 169.82 56.36 44.82
Bliss GVS Pharma 120.00 638.96 605.46 27.46 11.19
Ambalal Sarabhai 37.31 11.70 3.81 15.94 1.92